Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity

BACKGROUND: Diabetes mellitus (DM) is a common concomitant disease of late-onset myasthenia gravis (MG). However, the impacts of DM on the progression of late-onset MG were unclear. METHODS: In this study, we examined the immune response in experimental autoimmune myasthenia gravis (EAMG) rats with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peng, Yang, Chun-Lin, Du, Tong, Liu, Yu-Dong, Ge, Meng-Ru, Li, Heng, Liu, Ru-Tao, Wang, Cong-Cong, Dou, Ying-Chun, Duan, Rui-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549151/
https://www.ncbi.nlm.nih.gov/pubmed/34702288
http://dx.doi.org/10.1186/s12974-021-02298-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549151/
https://www.ncbi.nlm.nih.gov/pubmed/34702288
http://dx.doi.org/10.1186/s12974-021-02298-6

Ejemplares similares